Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.64 USD | +0.85% | +1.46% | -29.19% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.19% | 1.46B | |
-20.53% | 10.67B | |
+41.94% | 3.22B | |
-36.56% | 2.09B | |
-18.92% | 2.04B | |
+15.73% | 1B | |
-4.37% | 734M | |
-37.00% | 391M | |
-46.73% | 379M | |
+16.90% | 343M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Veracyte : SVB Leerink Adjusts Price Target on Veracyte to $60 From $55, Maintains Outperform Rating